Cobimetinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 1 CAS NO:NAchemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(piperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 1.We supply Cobimetinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142900 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142901 |
| CAS No | 29291-35-8 |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142902 |
| CAS No | 77313-99-6 |
| Mol.F. | C19H22N8O7 |
| Mol.Wt. | 474.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142903 |
| CAS No | NA |
| Mol.F. | C7H4N6O4 |
| Mol.Wt. | 236.15 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142904 |
| CAS No | NA |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142905 |
| CAS No | NA |
| Mol.F. | C21H21N5O4 |
| Mol.Wt. | 407.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142906 |
| CAS No | NA |
| Mol.F. | C21H20N4O5 |
| Mol.Wt. | 408.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142907 |
| CAS No | NA |
| Mol.F. | C24H23N5O5 |
| Mol.Wt. | 461.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142908 |
| CAS No | NA |
| Mol.F. | C19H17N5O4 |
| Mol.Wt. | 379.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142909 |
| CAS No | NA |
| Mol.F. | C21H23N5O6 |
| Mol.Wt. | 441.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142910 |
| CAS No | NA |
| Mol.F. | C21H23N5O5 |
| Mol.Wt. | 425.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142911 |
| CAS No | NA |
| Mol.F. | C21H21N5O5 |
| Mol.Wt. | 423.43g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142912 |
| CAS No | NA |
| Mol.F. | C19H16N4O5 |
| Mol.Wt. | 380.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142913 |
| CAS No | NA |
| Mol.F. | C21H23N5O5 |
| Mol.Wt. | 425.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142914 |
| CAS No | NA |
| Mol.F. | C22H23N5O4 |
| Mol.Wt. | 421.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142915 |
| CAS No | NA |
| Mol.F. | C20H19N5O4 |
| Mol.Wt. | 393.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |